Anthem Biosciences Limited has informed the Exchange about Schedule of meet
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed the exchanges that it will host an earnings conference call on Thursday, August 14, 2025 at 12:00 PM IST to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1FY26). The call will be moderated by Nomura's equity research team, with participation from the company's Managing Director and CEO Ajay Bhardwaj and CFO Gawir Baig. The company, which recently listed on NSE and BSE on July 21, 2025, operates as an integrated CRDMO serving biotech and pharmaceutical clients globally across small molecules, biologics, ADCs, peptides and oligonucleotides.
This is a routine regulatory intimation ahead of the company's first earnings call since listing. Investors should watch the call for actual Q1FY26 numbers and management commentary on business outlook, which could drive short-term stock sentiment.